Crescent Grove Advisors, LLC Exact Sciences Corp Transaction History

Crescent Grove Advisors, LLC

$934 Million
Q3 2024

A detailed history of Crescent Grove Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 14,045 shares of EXAS stock, worth $980,341. This represents 0.1% of its overall portfolio holdings.

Number of Shares

14,045

Previous 13,545 3.69%

Holding current value

$980,341

Previous $572,000 67.13%

% of portfolio

0.1%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$42.43 - $70.83 $21,215 - $35,415	500 Added 3.69%	14,045 $956,000
Q2 2024 Jul 22, 2024	BUY	$41.33 - $74.26 $91,669 - $164,708	2,218 Added 19.58%	13,545 $572,000
Q1 2024 Apr 29, 2024	BUY	$56.27 - $73.77 $16,881 - $22,131	300 Added 2.72%	11,327 $782,000
Q4 2023 Jan 30, 2024	BUY	$59.06 - $75.72 $30,534 - $39,147	517 Added 4.92%	11,027 $815,000
Q2 2023 Jul 13, 2023	SELL	$62.68 - $95.05 $32,593 - $49,426	-520 Reduced 4.71%	10,510 $986,000
Q1 2023 May 03, 2023	SELL	$47.19 - $70.77 $6,606 - $9,907	-140 Reduced 1.25%	11,030 $747,000
Q4 2022 Jan 12, 2023	SELL	$30.35 - $53.15 $16,540 - $28,966	-545 Reduced 4.65%	11,170 $0
Q3 2022 Nov 08, 2022	BUY	$31.97 - $49.37 $49,169 - $75,931	1,538 Added 15.11%	11,715 $381,000
Q2 2022 Jul 20, 2022	BUY	$35.61 - $76.23 $191,474 - $409,888	5,377 Added 112.02%	10,177 $401,000
Q3 2021 Oct 26, 2021	SELL	$90.24 - $124.05 $57,663 - $79,267	-639 Reduced 11.75%	4,800 $458,000
Q2 2021 Jul 26, 2021	BUY	$93.66 - $139.27 $64,531 - $95,957	689 Added 14.51%	5,439 $676,000
Q1 2021 May 07, 2021	BUY	$116.57 - $155.01 $57,119 - $75,954	490 Added 11.5%	4,750 $626,000
Q1 2020 Apr 27, 2020	BUY	$37.9 - $104.44 $379 - $1,044	10 Added 0.24%	4,260 $247,000
Q4 2019 Feb 03, 2020	SELL	$77.66 - $99.74 $38,830 - $49,870	-500 Reduced 10.53%	4,250 $393,000
Q3 2019 Oct 31, 2019	BUY	$90.37 - $122.49 $45,185 - $61,245	500 Added 11.76%	4,750 $429,000
Q2 2018 Jul 16, 2018	BUY	$37.84 - $69.96 $160,820 - $297,330	4,250 New	4,250 $254,000
Q1 2018 May 03, 2018	SELL	$39.82 - $57.53 $169,235 - $244,502	-4,250 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$37.05 - $47.12 $157,462 - $200,260	4,250	4,250 $200,000

Others Institutions Holding EXAS

# of Institutions

639

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12.4B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crescent Grove Advisors, LLC with notifications on news.

Account

Crescent Grove Advisors, LLC Exact Sciences Corp Transaction History